In 2024, the trade exchange (includes international purchases and sales) of Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts) was US$44.9M.
In 2024, the states with the most international sales in Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts) were Estado de México (US$28.8k).
The states with the most international purchases in 2024 were Ciudad de México (US$12.7M), Jalisco (US$4.59M), Querétaro (US$3.6M), Estado de México (US$1.09M), and Nuevo León (US$487k).
In 2024, the main commercial destinations of Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts) were Guatemala (US$19.5k), Panama (US$5.75k), Brazil (US$1.93k), El Salvador (US$712), and Argentina (US$508).
The main commercial origins of Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts) in 2024 were United States (US$6.98M), China (US$6.74M), Germany (US$4.8M), Japan (US$1.84M), and Philippines (US$1.79M).
In the global context, the main exporting countries of Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts) in 2022 were China (US$632M), Germany (US$242M), and United States (US$189M). In the same year, the main importing countries of Acyclic Monoamines and their Derivatives; Salts Thereof (Excl. Mono-, Di- or Trimethylamine, Diethylamine and their Salts) were United States (US$220M), Germany (US$133M), and South Korea (US$105M).